Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.
Diabetes Care
; 36(12): 4015-21, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24186878
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Pirazinas
/
Triazóis
/
Compostos Benzidrílicos
/
Glicemia
/
Diabetes Mellitus Tipo 2
/
Glucosídeos
/
Metformina
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Diabetes Care
Ano de publicação:
2013
Tipo de documento:
Article